This Biotech Stock 355% Breakout: Deep Track Bets Big
A biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
Maintaining momentum mid month requires steady approaches. Discover ways to keep your budget on track mid month and stay aligned with goals.
25,694 articlesA biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
An FDA leadership shakeup deepens as Tracy Hoeg publicly says she was fired, prompting questions about regulatory dir...
Oil surged to $114 intraday earlier this year, forcing a rethink on how investors access crude exposure. Traders now ...
Meta Platforms trades around $630 amid 2026 market volatility, but bulls say rising ad pricing and early AI monetizat...
Investors are weighing whether HOOD deserves a place in a modern portfolio. This guide helps you gauge signals, risks...
Three heavyweight asset managers have pulled back sharply on private credit fears. This piece explains why these fina...
SpaceX faced its first red day since its IPO, dropping about 5% as broad markets slipped. This article breaks down wh...
The GTLB story has investors buzzing about whether a rebound is ahead. Even as revenue trends stay strong, the stock ...
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Roku stock has slipped about 17% year-to-date, even as the company shows improving profitability and optimism for gro...
A $103 million exit during a 37% sector rally raises big questions for investors. This article explains what happened...